ALSV
KDNY

ATP Life Science Ventures’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

ATP Life Science Ventures’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,028,937
Closed -$62.6M – 3
2021
Q1 		$62.6M Hold
4,028,937
– – 6.97% 3
2020
Q4 		$63.9M Buy
+4,028,937
New +$63.9M 4.93% 3